Article Details
Retrieved on: 2023-12-01 21:22:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024.
Article found on: www.cnbc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here